AKT1 and breast cancer: Similarly, in breast cancer, exosomal miR-27a-3p upregulates PD-L1 in macrophages to inhibit T cell function; however, this is achieved by miR-27a-3p targeting MAGI2 to inhibit the activation of the PI3K/AKT signaling pathway by PTEN (39).